AMP
43
2
LRCX
56
4
EW
55
5
EBAY
42
2
NSC
33
6
XRX
48
2
NDAQ
46
2
RCL
74
5
M
40
3
CME
59
3
COF
48
3
OMC
37
2
TXN
29
4
ICE
53
5
PRU
39
3
NEM
30
2
AON
25
4
TGNA
48
5
TGT
35
4
TRV
34
4
AMP
43
2
LRCX
56
4
EW
55
5
EBAY
42
2
NSC
33
6
XRX
48
2
NDAQ
46
2
RCL
74
5
M
40
3
CME
59
3
COF
48
3
OMC
37
2
TXN
29
4
ICE
53
5
PRU
39
3
NEM
30
2
AON
25
4
TGNA
48
5
TGT
35
4
TRV
34
4
Financhill
Back

UroGen Pharma Vs. Arbutus Biopharma Industry Stock Comparison

Sell
22

URGN
UroGen Pharma

Last Price:
$10.66
Seasonality Move:
-3.79%
Sell
27

ABUS
Arbutus Biopharma

Last Price:
$3.20
Seasonality Move:
21.65%
Sell
22
UroGen Pharma (URGN) is a Sell

Is UroGen Pharma a Buy, Sell or Hold?

  • The current UroGen Pharma [URGN] share price is $10.67. The Score for URGN is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.21. The Score for ABUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

URGN Stock Price Chart

What is UroGen Pharma's stock price today?

  • The UroGen Pharma share price today is $10.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight selling pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.

URGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 30.29 Sell
Chaikin Money Flow: -612616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.1 - 12.42) Sell
Bollinger Bands (100): (11.7 - 14.2) Sell

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 33.79 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.35 - 3.65) Sell
Bollinger Bands (100): (3.53 - 4.11) Sell

URGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.14 Sell
20-day SMA: 11.89 Sell
50-day SMA: 12.03 Sell
200-day SMA: 13.95 Sell
8-day EMA: 11.14 Sell
20-day EMA: 11.58 Sell
50-day EMA: 12.09 Sell
200-day EMA: 13.45 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.41 Sell
20-day SMA: 3.5 Sell
50-day SMA: 3.71 Sell
200-day SMA: 3.44 Sell
8-day EMA: 3.37 Sell
20-day EMA: 3.49 Sell
50-day EMA: 3.63 Sell
200-day EMA: 3.44 Sell

UroGen Pharma Earnings Growth & URGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

UroGen Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):